Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$8.91 -0.32 (-3.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Selling, General & Administrative (2011 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) reported Selling, General & Administrative of $35.96 million for Q2 2026, up 121.9% from $16.2 million a year earlier and up 25.6% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Selling, General & Administrative (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tonix Pharmaceuticals Holding's Selling, General & Administrative came in at $125.96 million, up 154.0% year-over-year; for FY2025, it was $87.68 million, up 118.7% from FY2024.

  • Selling, General & Administrative has increased for eight consecutive years, with a five-year compound annual growth rate of 43.6% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $40.1 million in FY2024 (+15.4%), $34.75 million in FY2023 (+15.0%), $30.22 million in FY2022 (+28.7%) and $23.47 million in FY2021 (+63.5%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2011.
  • Year over year, Selling, General & Administrative has now increased in each of the last seven quarters, with growth averaging 101.8% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2025 (growth of 233.5%); the low point was Q3 2024 (a decline of 11.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $28.62 million (Q1 2026), $35.68 million (Q4 2025) and $25.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Tonix Pharmaceuticals Holding 149.62 Mn 149.62 Mn 12.84 Mn 35.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.96 Mn
Mar 31, 2026 28.62 Mn
Dec 31, 2025 35.68 Mn
Sep 30, 2025 25.70 Mn
Jun 30, 2025 16.20 Mn
Mar 31, 2025 10.10 Mn
Dec 31, 2024 15.58 Mn
Sep 30, 2024 7.71 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 9.31 Mn
Dec 31, 2023 11.62 Mn
Sep 30, 2023 8.71 Mn
Jun 30, 2023 7.03 Mn
Mar 31, 2023 7.39 Mn
Dec 31, 2022 8.05 Mn
Sep 30, 2022 7.39 Mn
Jun 30, 2022 6.76 Mn
Mar 31, 2022 8.01 Mn
Dec 31, 2021 7.18 Mn
Sep 30, 2021 5.45 Mn
API Access

Tonix Pharmaceuticals Holding Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TNXP&period=max&api_key=YOUR_API_KEY